An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)
for Guillain-Barre Syndrome
12 locations incl. Phoenix
Sponsor: Annexon, Inc.
Sex: All·Age: 12 - 85
Code: NCT07020819·Phase 3·Recruiting